Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 59

1.

Tezosentan, an endothelin receptor antagonist, limits liver injury in endotoxin challenged cirrhotic rats.

Urbanowicz W, Sogni P, Moreau R, Tazi KA, Barriere E, Poirel O, Martin A, Guimont MC, Cazals-Hatem D, Lebrec D.

Gut. 2004 Dec;53(12):1844-9.

PMID:
15542526
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Innate immunity via Toll-like receptors and Nod proteins.

Athman R, Philpott D.

Curr Opin Microbiol. 2004 Feb;7(1):25-32. Review.

PMID:
15036136
[PubMed - indexed for MEDLINE]
3.

Coagulation disorders in patients with cirrhosis and severe sepsis.

Plessier A, Denninger MH, Consigny Y, Pessione F, Francoz C, Durand F, Francque S, Bezeaud A, Chauvelot-Moachon L, Lebrec D, Valla DC, Moreau R.

Liver Int. 2003 Dec;23(6):440-8.

PMID:
15002397
[PubMed - indexed for MEDLINE]
4.

Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial.

Hou MC, Lin HC, Liu TT, Kuo BI, Lee FY, Chang FY, Lee SD.

Hepatology. 2004 Mar;39(3):746-53.

PMID:
14999693
[PubMed - indexed for MEDLINE]
5.

Cirrhosis as a risk factor for sepsis and death: analysis of the National Hospital Discharge Survey.

Foreman MG, Mannino DM, Moss M.

Chest. 2003 Sep;124(3):1016-20.

PMID:
12970032
[PubMed - indexed for MEDLINE]
6.

Peripheral blood mononuclear cell expression of toll-like receptors and relation to cytokine levels in cirrhosis.

Riordan SM, Skinner N, Nagree A, McCallum H, McIver CJ, Kurtovic J, Hamilton JA, Bengmark S, Williams R, Visvanathan K.

Hepatology. 2003 May;37(5):1154-64.

PMID:
12717397
[PubMed - indexed for MEDLINE]
7.

Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells.

Paik YH, Schwabe RF, Bataller R, Russo MP, Jobin C, Brenner DA.

Hepatology. 2003 May;37(5):1043-55.

PMID:
12717385
[PubMed - indexed for MEDLINE]
8.

Liver in sepsis and systemic inflammatory response syndrome.

Szabo G, Romics L Jr, Frendl G.

Clin Liver Dis. 2002 Nov;6(4):1045-66, x. Review.

PMID:
12516206
[PubMed - indexed for MEDLINE]
9.

Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients.

Rayes N, Seehofer D, Hansen S, Boucsein K, Müller AR, Serke S, Bengmark S, Neuhaus P.

Transplantation. 2002 Jul 15;74(1):123-7.

PMID:
12134110
[PubMed - indexed for MEDLINE]
10.

Selective decontamination of the digestive tract to prevent postoperative infection: a randomized placebo-controlled trial in liver transplant patients.

Zwaveling JH, Maring JK, Klompmaker IJ, Haagsma EB, Bottema JT, Laseur M, Winter HL, van Enckevort PJ, TenVergert EM, Metselaar HJ, Bruining HA, Slooff MJ.

Crit Care Med. 2002 Jun;30(6):1204-9.

PMID:
12072669
[PubMed - indexed for MEDLINE]
11.

Activation of endothelial cell protease activated receptor 1 by the protein C pathway.

Riewald M, Petrovan RJ, Donner A, Mueller BM, Ruf W.

Science. 2002 Jun 7;296(5574):1880-2.

PMID:
12052963
[PubMed - indexed for MEDLINE]
Free Article
12.

Failure of Lactobacillus spp. to prevent bacterial translocation in a rat model of experimental cirrhosis.

Bauer TM, Fernández J, Navasa M, Vila J, Rodés J.

J Hepatol. 2002 Apr;36(4):501-6.

PMID:
11943421
[PubMed - indexed for MEDLINE]
13.

Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.

Fernández J, Navasa M, Gómez J, Colmenero J, Vila J, Arroyo V, Rodés J.

Hepatology. 2002 Jan;35(1):140-8.

PMID:
11786970
[PubMed - indexed for MEDLINE]
14.

Presence of bacterial infection in bleeding cirrhotic patients is independently associated with early mortality and failure to control bleeding.

Vivas S, Rodriguez M, Palacio MA, Linares A, Alonso JL, Rodrigo L.

Dig Dis Sci. 2001 Dec;46(12):2752-7.

PMID:
11768269
[PubMed - indexed for MEDLINE]
15.

Increased formation of S-nitrothiols and nitrotyrosine in cirrhotic rats during endotoxemia.

Ottesen LH, Harry D, Frost M, Davies S, Khan K, Halliwell B, Moore K.

Free Radic Biol Med. 2001 Sep 15;31(6):790-8.

PMID:
11557317
[PubMed - indexed for MEDLINE]
16.

Low levels of protein C are associated with poor outcome in severe sepsis.

Yan SB, Helterbrand JD, Hartman DL, Wright TJ, Bernard GR.

Chest. 2001 Sep;120(3):915-22.

PMID:
11555529
[PubMed - indexed for MEDLINE]
17.

Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study.

Borzio M, Salerno F, Piantoni L, Cazzaniga M, Angeli P, Bissoli F, Boccia S, Colloredo-Mels G, Corigliano P, Fornaciari G, Marenco G, Pistarà R, Salvagnini M, Sangiovanni A.

Dig Liver Dis. 2001 Jan-Feb;33(1):41-8.

PMID:
11303974
[PubMed - indexed for MEDLINE]
18.

Efficacy and safety of recombinant human activated protein C for severe sepsis.

Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr; Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group.

N Engl J Med. 2001 Mar 8;344(10):699-709.

PMID:
11236773
[PubMed - indexed for MEDLINE]
Free Article
19.

Bacterial translocation of enteric organisms in patients with cirrhosis.

Cirera I, Bauer TM, Navasa M, Vila J, Grande L, Taurá P, Fuster J, García-Valdecasas JC, Lacy A, Suárez MJ, Rimola A, Rodés J.

J Hepatol. 2001 Jan;34(1):32-7.

PMID:
11211904
[PubMed - indexed for MEDLINE]
20.

Current management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis.

Garcia-Tsao G.

Gastroenterology. 2001 Feb;120(3):726-48. Review. No abstract available.

PMID:
11179247
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk